Ibuprofen treatment after the first days of life in preterm neonates with patent ductus arteriosus

References

• Clyman RI. The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia. Semin Perinatol. 2013;37(2):102–107.
   PubMed Web of Science ®Google Scholar
• Laughon M, Bose C, Clark R. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes. J Perinatol. 2007;27(3):164–170.
   PubMed Web of Science ®Google Scholar
• Merritt TA, DiSessa TG, Feldman BH, et al. Closure of the patent ductus arteriosus with ligation and indomethacin: a consecutive experience. J Pediatr. 1978;93(4):639–646.
   PubMed Web of Science ®Google Scholar
• Varvarigou A, Bardin CL, Beharry K, et al. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA. 1996;275(7):539–544.
   PubMed Web of Science ®Google Scholar
• Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2011;(7):CD004213.
   PubMed Web of Science ®Google Scholar
• Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2013;(4):CD003481.
   PubMed Web of Science ®Google Scholar
• Neumann R, Schulzke SM, Bührer C. Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Neonatology. 2012;102(1):9–15.
   PubMed Web of Science ®Google Scholar
• Lainwala S, Hussain N. Treatment of patent ductus arteriosus with cyclo-oxygenase inhibitors beyond 2 weeks of age in very low birth weight infants. Am J Perinatol. 2016;33(6):584–589.
   PubMed Web of Science ®Google Scholar
• Sosenko IR, Fajardo MF, Claure N, et al. Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial. J Pediatr. 2012;160(6):929–35.e1.
   PubMed Web of Science ®Google Scholar
• Hirt D, Van Overmeire B, Treluyer JM, et al. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. Br J Clin Pharmacol. 2008;65(5):629–636.
   PubMed Web of Science ®Google Scholar
• Roofthooft DW, van Beynum IM, de Klerk JC, et al. Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure. Eur J Pediatr. 2015;174(11):1433–1440.
   PubMed Web of Science ®Google Scholar
• Weisz DE, Mirea L, Rosenberg E, et al. Association of patent ductus arteriosus ligation with death or neurodevelopmental impairment among extremely preterm infants. JAMA Pediatr. 2017;171(5):443–449.
   PubMed Web of Science ®Google Scholar
• Weisz DE, More K, McNamara PJ, et al. PDA ligation and health outcomes: a meta-analysis. Pediatrics. 2014;133(4):e1024–e1046.
   PubMed Web of Science ®Google Scholar
• Sung SI, Chang YS, Chun JY, et al. Mandatory closure versus nonintervention for patent ductus arteriosus in very preterm infants. J Pediatr. 2016;177:66–71.e1.
   PubMed Web of Science ®Google Scholar
• Letshwiti JB, Semberova J, Pichova K, et al. A conservative treatment of patent ductus arteriosus in very low birth weight infants. Early Hum Dev. 2017;104:45–49.
   PubMed Web of Science ®Google Scholar
• Hundscheid T, Onland W, van Overmeire B, et al. Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial). BMC Pediatr. 2018;18(1):262.
   PubMed Web of Science ®Google Scholar
• Slaughter JL, Reagan PB, Bapat RV, et al. Nonsteroidal anti-inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children’s hospitals. Eur J Pediatr. 2016;175(6):775–783.
   PubMed Web of Science ®Google Scholar
• Jain A, Shah PS. Diagnosis, evaluation, and management of patent ductus arteriosus in preterm neonates. JAMA Pediatr. 2015;169(9):863–872.
   PubMed Web of Science ®Google Scholar
• Hagadorn JI, Brownell EA, Trzaski JM, et al. Trends and variation in management and outcomes of very low-birth-weight infants with patent ductus arteriosus. Pediatr Res. 2016;80(6):785–792.
   PubMed Web of Science ®Google Scholar
• Van Overmeire B, Allegaert K, Casaer A, et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2004;364(9449):1945–1949.
   PubMed Web of Science ®Google Scholar
• Rolland A, Shankar-Aguilera S, Diomandé D, et al. Natural evolution of patent ductus arteriosus in the extremely preterm infant. Arch Dis Child Fetal Neonatal Ed. 2015;100(1):F55–F58.
   PubMed Web of Science ®Google Scholar
• Dani C, Vangi V, Bertini G, et al. High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study. Clin Pharmacol Ther. 2012;91(4):590–596.
   PubMed Web of Science ®Google Scholar
• Meißner U, Chakrabarty R, Topf HG, et al. Improved closure of patent ductus arteriosus with high doses of ibuprofen. Pediatr Cardiol. 2012;33(4):586–590.
   PubMed Web of Science ®Google Scholar
• Allegaert K. The impact of ibuprofen or indomethacin on renal drug clearance in neonates. J Matern Fetal Neonatal Med. 2009;22( 3):88–91.
   PubMed Web of Science ®Google Scholar
• Zonnenberg I, de Waal K. The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review. Acta Paediatr. 2012;101(3):247–251.
   PubMed Web of Science ®Google Scholar
• Perez KM, Laughon MM. What is new for patent ductus arteriosus management in premature infants in 2015? Curr Opin Pediatr. 2015;27(2):158–164.
   PubMed Web of Science ®Google Scholar
• Bourgoin L, Cipierre C, Hauet Q, et al. Neurodevelopmental outcome at 2 years of age according to patent ductus arteriosus management in very preterm infants. Neonatology. 2016;109(2):139–146.
   PubMed Web of Science ®Google Scholar
• de Freitas Martins F, Ibarra Rios D, F Resende MH, et al. Relationship of patent ductus arteriosus size to echocardiographic markers of shunt volume. J Pediatr. 2018;202:50–55.e3.
   PubMed Web of Science ®Google Scholar
• van Laere D, van Overmeire B, Gupta S, et al. Application of NPE in the assessment of a patent ductus arteriosus. Pediatr Res. 2018;84(l 1):46–56.
   PubMed Web of Science ®Google Scholar